Actively Recruiting
Characterization of Patients at High Risk for the Acquisition of Sexually Transmitted Infection With HIV - a Clinical Study
Led by Medical University of Vienna · Updated on 2022-04-13
500
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
This research aims to understand how new HIV infections occur among people at high risk due to their sexual behaviors. It focuses on individuals who are HIV-negative men who have sex with men (MSM) and transgender people, particularly those who engage in unsafe sex, have recently had a sexually transmitted infection (STI), used post-exposure prophylaxis (PEP), or frequently participate in 'chemsex'. The study is observational and conducted by the Medical University of Vienna to provide insights into HIV transmission and related infections. Participants will be observed over a period of up to 10 years without receiving any treatment as part of the study. Researchers will collect important clinical information related to sexual behaviors, use of HIV pre-exposure prophylaxis, and occurrence of other STIs. Laboratory tests will be performed on blood, urine, and mucosal samples to monitor infections and related health factors. During the study, participants will provide medical history and behavioral information through assessments. Researchers will monitor the incidence of new HIV infections and other sexually transmitted infections throughout the study period. The study involves regular collection of samples and clinical data, with safety and well-being monitored as part of the observational process.
CONDITIONS
Brief Title
Vienna HIV Infection Via Sex Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- High risk for acquiring HIV: HIV-negative men who have sex with men (MSM) and transgender individuals who do not consistently use condoms with casual partners or untreated HIV-positive partners, or who recently had an STI, used PEP, or frequently engage in 'chemsex'
- Age greater than 18 years and less than 100 years
- Written informed consent for this registry study
You will not qualify if you...
- Withdrawal of the written informed consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 10 years
Participants are observed over time to assess HIV acquisition and incidence of sexually transmitted infections through clinical information and laboratory tests.
Visits scheduled periodically for clinical and laboratory assessments
Trial Site Locations
Total: 1 location
1
Medical University of Vienna
Vienna, Austria, 1090
Actively Recruiting
Research Team
D
David Chromy, MD
A
Armin Rieger, MD
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here